Letter to Shareholders and Employees

To Our Shareholders and Employees:
The past year was an extraordinary one for Boston Scientific. At every level of the organization, we demonstrated to clinicians and patients the meaning of Delivering what’s next.

Most notably, this was the year we positioned ourselves to become the global leader in the treatment of coronary artery disease. We expect to achieve that leadership quickly, and the impact on Boston Scientific will be profound. The growth we anticipate in 2004 and beyond will help create a host of opportunities in the coming years.